These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48 related articles for article (PubMed ID: 3263710)
21. Evaluation and clinical application of a new method for measuring activity of von Willebrand factor-cleaving metalloprotease (ADAMTS13). Böhm M; Vigh T; Scharrer I Ann Hematol; 2002 Aug; 81(8):430-5. PubMed ID: 12223999 [TBL] [Abstract][Full Text] [Related]
22. Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays? Favaloro EJ; Thom J; Patterson D; Just S; Dixon T; Koutts J; Baccala M; Rowell J; Baker R Thromb Res; 2009 Apr; 123(6):862-8. PubMed ID: 19064279 [TBL] [Abstract][Full Text] [Related]
23. Increased von Willebrand factor (vWf) binding to platelets associated with impaired vWf breakdown in thrombotic thrombocytopenic purpura. Moake JL; Chow TW J Clin Apher; 1998; 13(3):126-32. PubMed ID: 9828023 [TBL] [Abstract][Full Text] [Related]
24. Abnormal platelet von Willebrand factor interaction in patients with TTP. Rock G; Tittley P; Taylor JR Am J Hematol; 1988 Mar; 27(3):179-83. PubMed ID: 3126651 [TBL] [Abstract][Full Text] [Related]
25. Thrombotic thrombocytopenic purpura in a patient with rapidly progressive scleroderma. Bohgaki T; Notoya A; Mukai M; Kohno M Mod Rheumatol; 2000 Dec; 10(4):256-9. PubMed ID: 24383639 [TBL] [Abstract][Full Text] [Related]
26. von Willebrand factor antigen compared with other factors in vasculitic syndromes. Ateş E; Bakkaloğlu A; Saatçi U; Söylemezoğlu O Arch Dis Child; 1994 Jan; 70(1):40-3. PubMed ID: 7906508 [TBL] [Abstract][Full Text] [Related]
27. Intraoperative investigation of von Willebrand factor structure and function in orthotopic liver transplantation. The Liver Transplantation Group. Monteagudo J; Reverter JC; Mateo D; Seoane R; Mazzara R; Escolar G; Pereira A; Castillo R; Visa J Transplant Proc; 1990 Aug; 22(4):1531-2. PubMed ID: 2389391 [No Abstract] [Full Text] [Related]
28. Primary thrombocythaemia: a composite approach to diagnosis. Messinezy M; Westwood N; Sawyer B; Grace R; Holland LJ; Lawrie AS; Pearson TC Clin Lab Haematol; 1994 Jun; 16(2):139-48. PubMed ID: 7955922 [TBL] [Abstract][Full Text] [Related]
29. Endothelial Activation and Immune Thrombocytopenia: An Engagement Waiting for Consolidation. Efat A; Shoeib S; Nazir A; Abdelmohsen E; Dawod A; Bedair HM; Elgheriany W Clin Appl Thromb Hemost; 2021; 27():10760296211054514. PubMed ID: 34806423 [TBL] [Abstract][Full Text] [Related]
30. Quantitation of serum prostacyclin-binding in thrombotic thrombocytopenic purpura. Tsai AL; Manner CE; Rudersdorf T; Wu KK Thromb Res; 1988 Sep; 51(6):583-92. PubMed ID: 3055418 [TBL] [Abstract][Full Text] [Related]
31. Recurrence of thrombocytopenia in previously diagnosed thrombotic thrombocytopenia purpura (TTP) does not always mean TTP recurrence. Jaafar H; Alizadeh H; Kristensen J; Zwaan F Ann Saudi Med; 2003; 23(3-4):228-9. PubMed ID: 16985332 [No Abstract] [Full Text] [Related]
32. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio. Gadisseur A; Berneman Z; Schroyens W; Michiels JJ Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359 [TBL] [Abstract][Full Text] [Related]
33. Further evidence of von Willebrand factor involvement in thrombotic thrombocytopenia purpura. Chediak J; Eldridge J; Bergmann F; Sobel D; Baron J; Maxey B; Telfer MC Thromb Haemost; 1988 Aug; 60(1):13-7. PubMed ID: 3263710 [TBL] [Abstract][Full Text] [Related]
34. [Multimeric composition of von Willebrand factor in thrombotic thrombocytopenic purpura. Japanese TTP Study Group]. Tatewaki W Nihon Rinsho; 1993 Jan; 51(1):146-50. PubMed ID: 8433508 [TBL] [Abstract][Full Text] [Related]
35. Plasma von Willebrand Factor Antigen (vWF:AG) and thrombomodulin (TM) levels in Adult Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM). Zeigler ZR; Rosenfeld CS; Andrews DF; Nemunaitis J; Raymond JM; Shadduck RK; Kramer RE; Gryn JF; Rintels PB; Besa EC; George JN Am J Hematol; 1996 Dec; 53(4):213-20. PubMed ID: 8948657 [TBL] [Abstract][Full Text] [Related]
36. Diagnosis and follow-up of thrombotic thrombocytopenic purpura by means of von Willebrand factor collagen binding assay. Casonato A; Fabris F; Pontara E; Cattini MG; Zocca N; Gallinaro L; Girolami A; Pagnan A Clin Appl Thromb Hemost; 2006 Jul; 12(3):296-304. PubMed ID: 16959682 [TBL] [Abstract][Full Text] [Related]